The saga of drug development

Author： Walton M.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.22, Iss.12, 2001-12, pp. : 646-646

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug-Glycosidation and Drug Development

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 4, 2013-04 ,pp. : 584-596

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Development in Japan: Opportunities and Challenges in Drug Development

By Takahashi Kihito  

International Journal of Pharmaceutical Medicine, Vol. 21, Iss. 5, 2007-01 ,pp. : 331-338

Adis International

Access to resources Recommend Favorite

Atherosclerosis imaging in drug development

By Nicholls Stephen J   Kalidindi Srinivasa   Moon Keon-Woong   Nissen Steven E  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 9, 2007-09 ,pp. : 1241-1250

Informa Healthcare

Access to resources Recommend Favorite

Metabonomics in preclinical drug development

By Robertson Donald G   Reily Michael D   Baker J David  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 3, 2005-10 ,pp. : 363-376

Informa Healthcare

Access to resources Recommend Favorite

Induction and drug development

By Smith D.A.  

European Journal of Pharmaceutical Sciences, Vol. 11, Iss. 3, 2000-09 ,pp. : 185-189

Elsevier

Access to resources Recommend Favorite